High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study
Lingdi Zhao(Zhengzhou University), Quanli Gao(Zhengzhou University), Baozhen Ma(Henan Cancer Hospital), Tiepeng Li(East China Normal University), Xiaomin Fu(Zhengzhou University), Jindong Guo(Henan Cancer Hospital), Hongwei Lin(Zhengzhou University), Yonghao Yang(Army Medical University), Liang Liu(Sun Yat-sen University), Yong Zhang, Benling Xu(Zhengzhou University), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Lu Han(Liaoning Cancer Hospital & Institute), Peng Qin(Shenzhen Bay Laboratory), Yiman Shang(Henan Cancer Hospital), Yongping Song(Zhengzhou University), Zibing Wang(Huazhong University of Science and Technology)
Cited by 15
Related Papers
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|705
Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer
|European Radiology|2019|198
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
|Frontiers in Immunology|2021|73